Biosafety considerations in handling medically important fungi

A. A. Padhye, J. E. Bennett, M. R. McGinnis, L. Sigler, A. Flis, I. F. Salkin

Research output: Contribution to journalArticle

Abstract

Over 500,000 workers in the USA alone are employed in laboratories that range from small physician offices to large clinical laboratories handling microbes for comprehensive research and/or diagnostic work. These workers are exposed to a variety of potential occupational health risks such as exposure to infectious clinical materials, environmental specimens, cultures, complex and inflammable chemicals, radiation, and electrical and mechanical hazards. As members of the International Society for Human and Animal Mycology, we have no policy statement on biosafety standards for handling medically important fungi. The intent of the symposium is to cover some of the important aspects of biosafety; (1) standards in handling dimorphic fungal pathogens; (2) the principles and criteria of biosafety levels and classification of known medically important fungi, aerobic actinomycetes, environmental fungi according to their biosafety levels; (3) medically important fungal waste and its safe disposal; and (4) biosafety and regulatory considerations in handling and mailing medically important fungi in a culture collection.

Original languageEnglish (US)
Pages (from-to)258-265
Number of pages8
JournalMedical Mycology, Supplement
Volume36
Issue number1
StatePublished - Dec 1 1998

Keywords

  • Biosafety principles
  • Fungal waste disposal
  • Mailing of pathogenic fungi
  • Medically important fungi

ASJC Scopus subject areas

  • Microbiology
  • Immunology

Fingerprint Dive into the research topics of 'Biosafety considerations in handling medically important fungi'. Together they form a unique fingerprint.

  • Cite this

    Padhye, A. A., Bennett, J. E., McGinnis, M. R., Sigler, L., Flis, A., & Salkin, I. F. (1998). Biosafety considerations in handling medically important fungi. Medical Mycology, Supplement, 36(1), 258-265.